Pages that link to "Q40946383"
Jump to navigation
Jump to search
The following pages link to Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methods (Q40946383):
Displaying 18 items.
- Variation in susceptibility patterns of species within the Bacteroides fragilis group (Q33727442) (← links)
- Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin (Q33728101) (← links)
- Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes. (Q33903294) (← links)
- The distribution of Bacteroides fragilis serotypes amongst clinical strains (Q36250694) (← links)
- Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis (Q36475771) (← links)
- Collaborative evaluation of the micro-media systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibility (Q37296087) (← links)
- Factors affecting production of catalase by Bacteroides (Q37365054) (← links)
- In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria (Q39849981) (← links)
- Rapid identification of Bacteroides fragilis with bile and antibiotic disks (Q40236214) (← links)
- Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species (Q40271900) (← links)
- Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin (Q40281987) (← links)
- Susceptibility to beta-lactam antibiotics and production of beta-lactamase inBacteroides fragilis (Q40355354) (← links)
- Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis (Q40617355) (← links)
- Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates (Q40617694) (← links)
- Susceptibility of anaerobic bacteria to 23 antimicrobial agents (Q40947577) (← links)
- Antimicrobial Activity of Antituberculosis Agents against Anaerobic Bacteria (Q41551674) (← links)
- Modified broth-disk surveillance of clindamycin-resistant Bacteroides fragilis group (Q42929055) (← links)
- Identification and susceptibility patterns of anaerobic bacteria isolated from clinical specimens during a one-year period (Q70735819) (← links)